Utama › Penyakit Crohn › California › Los Angeles
Kajian klinikal Penyakit Crohn di Los Angeles, CA
15 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Mengambil pesertaFasa 3
- Cedars Sinai Medical Center ( Site 5080), Los Angeles
- UCLA Clinical & Translational Research Center (CTRC) ( Site 5116), Los Angeles
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
- Cedars Sinai Medical Center, Los Angeles
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 2/3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Mengambil pesertaFasa 3
- TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles
- GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Mengambil pesertaFasa 2
- Biopharma Informatic, LLC, Los Angeles
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Mengambil pesertaFasa 2
- Biopharma Informatic, LLC, Los Angeles
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Mengambil pesertaFasa 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Mengambil pesertaFasa 3
- Cedars Sinai Medical Center, Los Angeles
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Mengambil peserta
- Cedars-Sinai, Los Angeles
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Mengambil pesertaFasa 3
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Mengambil pesertaFasa 4
- Cedars-Sinai, Los Angeles
Precise Infliximab Exposure and Pharmacodynamic Control
Mengambil pesertaFasa 2/3
- Children's Hospital of Los Angeles, Los Angeles
Impact of Prebiotics in Ulcerative Colitis
Mengambil peserta
- UCLA, Los Angeles
Stem Cell Transplantation in Crohn's Disease
Mengambil pesertaFasa 1/2
- Cedars-Sinai Medical Center, Los Angeles
Kajian Penyakit Crohn di bandar lain
- New York City, NY35 kajian
- Boston, MA19 kajian
- Miami, FL19 kajian
- Cleveland, OH19 kajian
- St. Louis, MO19 kajian
- Tyler, TX17 kajian
- Houston, TX17 kajian
- Orlando, FL17 kajian
- Atlanta, GA17 kajian
- San Antonio, TX15 kajian
- San Diego, CA15 kajian
- Colorado Springs, CO13 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)74 kajian
- Kanser Payudara73 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.